A pioneering partnership between researchers from The Grainger College of Engineering at the University of Illinois ...

A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust ...

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk ...

Peptides are among the most intriguing biomolecules investigated in scientific research. Despite their relatively simple structures, peptides are believed to exhibit complex interactions with ...

Blood clotting is a complex, tightly regulated process involving numerous molecular steps and myriad biomolecules to carry ...

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an unspecified up-front payment, research costs ...

Wegovy maker Novo Nordisk has hired the start-up Deep Apple Therapeutics to develop small molecules as its next weight-loss ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

"Let's say you wake up really hungry," says Lembas CTO Dr. Zohar Barbash. "You take the peptide and feel like you have just ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

New research led by scientists at the University of Birmingham suggests that treating psoriasis with a tripeptide-composed of ...